Trial Site Detail
Drug: |
IMC-A12 + CCI-779 |
|||
|---|---|---|---|---|
Trial: |
Cixutumumab and Temsirolimus in Treating Young Patients With Solid Tumors That Have Recurred or Not Responded to Treatment |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Suspended |
|||
Cincinnati Children's Hospital Medical Center3333 Burnet Ave. |
Principal Investigator: |
|
|---|---|
Contact: |
Clinical Trials Office 513-636-2799 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Cincinnati Children's Hospital Medical Center Website: |
http://www.cincinnatichildrens.org/research/trials/default.htm |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.